Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 228Recruiting 34Terminated 26Active not recruiting 25Unknown 19Withdrawn 13Not yet recruiting 3Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 307INDUSTRY 61OTHER_GOV 12NIH 4NETWORK 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 6Sarcoma 5Other hematologic neoplasm 5Breast 5Gastrointestinal 4Thoracic 3Other solid neoplasm 3Lymphoid 3Dermatologic 3Tumor-Agnostic 1Plasma cell 1Gynecologic 1CNS 1

Conditions

Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1

Interventions

prednylidene 1pegaspargase 1nelarabine 1merphos 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1daratumumab 1calaspargase pegol 1auricularum 1Vincristine 1Thioguanine 1Spinal Puncture 1Specimen Handling 1Radiotherapy 1Radiation 1Prednisone 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Medrol Veriderm 1Magnetic Resonance Spectroscopy 1Hydrocortisone 1High-Energy Shock Waves 1Doxorubicin 1Dexamethasone 1Daunorubicin 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Lymphoid × Clear all
NCT07072585 2025-12-31

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Children's Oncology Group

Phase 2/3 Not yet recruiting
1,708 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06757478 2025-03-18

A Clinical Study on the Combination of Mitoxantrone Liposome Injection, Bendamustine, Etoposide, and Cytarabine for Pretreatment of Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma

First Affiliated Hospital of Ningbo University

Not yet recruiting
30 enrolled
Lymphoid

Lymphoma

NCT06721598 2024-12-06

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

National Research Center for Hematology, Russia

Not yet recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡